Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High Dose Rate Brachytherapy vs Stereotactic Ablative Body Therapy in Patients With Early-intermediate Prostate Cancer

NCT04870567 is registered in ClinicalTrials.gov with N.N. Petrov National Medical Research Center of Oncology as lead sponsor.

NCT NCT04870567
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04870567 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High Dose Rate Brachytherapy vs Stereotactic Ablative Body Therapy in Patients With Early-intermediate Prostate Cancer
Lead sponsor
N.N. Petrov National Medical Research Center of Oncology
Phase
Not applicable
Overall status
Unknown status
Start date
April 1, 2018
Completion date
April 30, 2025
Enrollment
350 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biochemical relapse free survival, complications rates (erectile dysfunction, gi, gu complications)